Satisfaction with IUD High, Rate of Unprotected Sex Low after Placement Following Medical Abortion
IUD placement within 48 hours of medical abortion was associated with high satisfaction, continued use, and low rates of subsequent pregnancies, report Swedish investigators.
Expert Panel Offers Guidance on Testing for COVID-19, Influenza, RSV During Respiratory Virus Season 2023-2024
As flu season approaches this year, experts stress that it's not just about influenza anymore; they discuss testing, antiviral treatment, and management of coinfection.
Dapagliflozin Did Not Meet Primary Endpoint in DICTATE-AHF Trial of Patients with Acute Decompensated Heart Failure
ESC 2023: Early initiation of dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in patients hospitalized with ADHF.
Daily Dose: Semaglutide May Benefit 93 Million US Adults
A daily dose of clinical news on Patient Care you may have missed.
Frail Elderly at High Risk of Bleeding Following VKA-DOAC Switch: Surprise Outcome Shared at ESC Congress
Oldest and most frail elderly were at more than 60% greater risk of bleeding when switched from a VKA than those who remained on the traditional agent.
New-Onset Inflammatory Rheumatic Diseases May be Triggered by SARS-CoV-2 Infection or COVID-19 Vaccines, According to Recent Data
Findings from a recent study show a broad spectrum of possible clinical manifestations of IRD following SARS-CoV-2 infection or COVID-19 vaccination.
Semaglutide 2.4 mg Significantly Reduces HF Symptom Burden, Body Weight in Adults with HFpEF and Obesity
ESC Congress 2023. The results of STEP-HFpEF could "change the nature of the conversation about the role of obesity in HFpEF," said PI Mikhail Kosiborod, MD.
Remdesivir Gets FDA “OK” for COVID-19 Treatment in Hepatic Disease Across Stages
The expanded labeling for the antiviral against COVID-19 indicates no dose adjustment is required for persons across all stages of liver disease.
First Biosimilar for Multiple Sclerosis Wins FDA Approval
The first biosimilar to the approved formulation of natalizumab is indicated for relapsing forms of MS and for induction/maintenance of remission in adults with Crohn disease.
Consider Age when Assessing Children for COVID-19 Severity, Advise Authors of New Study
A large study of hospitalized children with SARS-CoV-2 infection found that disease severity varied by age over the course of the COVID-19 pandemic.
Cardiorenal Risk Estimates in T2D Mediated by Common Biomarker Response to Canagliflozin
Reduction in levels of 4 biomarkers was correlated with lower risk of composite cardiorenal outcomes in the CREDENCE trial, suggesting use of the panel to augment current risk assessment tools.
Daily Dose: Effect of Sotagliflozin on Heart Failure-Related Events
Aspirin Underused for Secondary Prevention of CVD Worldwide, Especially in Lower-Income Countries
In an analysis of participant data from health surveys, less than half of eligible persons in the overall pooled sample were taking aspirin for secondary prevention of CVD.
USPSTF Publishes Final Recommendation Statement on HIV PrEP
The USPSTF particularly emphasizes effective communication with patients, including adherence support and calls for reducing barriers to PrEP for racial, ethnic, and other minority groups.
Daily Dose: Characteristics of RSV-Related Critical Illness in Infants during 2022 Peak
Obesity Management in Primary Care: Tailor Nutrition Plans to Individual Patient Needs
Before creating a nutrition plan for patients with obesity, clinicians should first understand their eating patterns, says one obesity expert.
Top 10 Nonfatal Injuries Seen in US Emergency Departments
The most common nonfatal injuries are caused by unintentional falls; coming in at #10 are pedal cyclist injuries. Find out what calamities lie in between in a short slide show.
FDA Approves First RSV Vaccine for Use in Pregnant Individuals to Prevent LRTD in Infants
The FDA approved Abrysvo for use in pregnant individuals to prevent LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age.
The State of Vaccine Willingness in the US: A Primary Care and an Infectious Disease Physician Discuss
Well-known ID specialist Bill Schaffner, MD, and active primary care educator Chuck Vega, MD, offer thoughts on how to get shots into arms in the 2023-2024 respiratory virus season.
Daily Dose: Recreational Drug Use in Patients with Acute CV Events
